Background: Biliary phospholipids (PL) stimulate dietary fat absorption by facilitating
INTRODUCTION
Biliary phospholipids (PL) have a well-documented function in transport of dietary lipids from the intestinal lumen into lymph. Apart from their role in intraluminal lipid solubilization, biliary phospholipids have been implicated as crucial components for adequate intestinal chylomicron (CM) assembly and secretion into lymph (23) . Biliary phosphatidylcholines (PC), which compose ~95% of biliary phospholipids, provide the main source for chylomicron surface coating (13; 17; 20) , and the supply of bile PC to the intestine increases the synthesis of apoB48, the apolipoprotein needed for chylomicron formation (6; 14) . Additionally, the high essential fatty acid (EFA) content of biliary PC may be required for maintenance of normal intestinal mucosal membrane composition and function (7; 22) . Reduced availability of PC for hepatic VLDL assembly in rats has been associated with decreased VLDL secretion and with assembly of relatively large VLDL particles (24) . It is well-established that fat absorption and intestinal lipoprotein secretion are strongly impaired in situations of disturbed bile formation, such as cholestasis. Studies in rats with interrupted enterohepatic circulation by means of permanent bile diversion (23) demonstrated a substantial lipid accumulation in intestinal mucosal cells. Administration of bile salts to these bilediverted rats partially restored lymphatic lipid transfer, but only when both bile salts and biliary phospholipids were supplemented, lymphatic lipid transport was fully reinstated. Yet, a direct relationship between biliary phospholipid availability and intestinal lipoprotein size has not been established.
We recently characterized fat absorption in two mouse models with altered biliary phospholipid secretion (30) . EFA deficiency increases biliary phospholipid secretion bỹ 80%, in conjunction with a decrease by 30-40% in dietary lipid absorption.
In Mdr2 -/-mice, in which biliary phospholipid secretion is absent (21) , plasma appearance of enterally administered lipid is delayed and lipid accumulates in enterocytes. Quantitatively, however, lipid absorption is unaffected in these mice (26) .
In the present study, we investigated whether and to what extent quantitative or qualitative alterations in biliary phospholipid secretion affect chylomicron secretion into lymph. Chylomicron size and composition were measured after mesenteric lymph duct cannulation, using the aforementioned mouse models with altered intraluminal biliary phospholipid availability, i.e., Mdr2 -/-
MATERIALS AND METHODS

Animals
Mice homozygous for disruption of the multidrug resistance gene-2 (Mdr2 -/-) and wildtype (Mdr2 +/+ )mice with a free virus breed (FVB) background were obtained from the breeding colony at the Central Animal Facility, Academic Medical Center, Amsterdam, the Netherlands (8) . For dietary induction of EFA deficiency in mice, male wildtype FVB mice were obtained from Harlan (Horst, the Netherlands). All mice were 8 weeks old, weighed 25 to 35 gram and were housed in a light-controlled (lights on 6 AM -6 PM) and temperature-controlled (21°C) facility. Mice were allowed tap water and chow ad libitum. The experimental protocols were approved by the Ethics Committee for Animal Experiments, University of Groningen, the Netherlands.
Experimental diets
The standard laboratory low-fat chow (RMH-B, Arie Blok BV, Woerden, the Netherlands) contained 14 energy% fat. The high-fat EFA-deficient (EFAD) diet contained 34 energy% fat, and had the following fatty acid composition: 41.4 mol% palmitic acid (C16:0), 47.9 mol% stearic acid (C18:0), 7.7 mol% oleic acid (C18:1n-9) and 3 mol% linoleic acid (C18:2n-6). An isocaloric EFA-sufficient (EFAS) diet was used as control diet, containing 37 energy% fat with 32.1 mol% C16:0, 5.5 mol% C18:0, 32.2 mol% C18:1n-9 and 30.2 mol% C18:2n-6 (diet numbers 4141.08 (EFAD) and 4141.07 (EFAS), Arie Blok BV, Woerden, the Netherlands).
Experimental procedures
Induction of EFA deficiency in mice
All mice were fed standard laboratory chow from weaning. For induction of EFA deficiency, wildtype FVB mice were fed the EFA-deficient (EFAD) diet for eight weeks.
A control group of FVB mice was fed the isocaloric EFA-sufficient (EFAS) diet for eight weeks. This method for induction of EFA deficiency was previously applied in mice and characterized by our group (15; 29; 30) .
Mesenteric lymph duct cannulation in mice
Cannulation of the mesenteric lymph duct was performed according to procedures described by Wang et al. (27; 28) Non-fasted mice were anesthetized with halothane/NO 2 and dorsally arched over a cotton cylinder for optimal visualization of the mesenteric lymph duct. After extra-abdominal displacement of the intestine, the common mesenteric lymph duct was exposed by removal of surrounding tissues and membranes using a blunt mini-kocher. A 0.305 x 0.635 mm (id x od) silicone catheter was introduced through the abdominal wall and positioned parallel to the lymph duct.
Subsequently, the catheter was carefully inserted into a small incision in the 
Determination of lymphatic lipoprotein size and composition
Lymphatic lipoprotein size and volume distribution profiles were analyzed within 6 hours after lymph collection by dynamic light scattering techniques, using a Nicomp model 370 submicron particle analyzer (Nicomp Particle sizing Systems, Santa Barbara, CA, USA). Particle diameters were calculated from the volume distribution patterns provided by the analyzer. The lymphatic chylomicron (CM) fraction (d<1.006) was isolated after complementing collected lymph with a 1.006 g/ml NaCl solution containing 0.02% NaN 3 to a final volume of 1 ml, and subsequent centrifugation at 40000 rpm at 4°C in an Optima TM LX table top centrifuge (Beckman Instruments, Inc., Palo Alto, CA, USA) for 15 minutes. The top layer containing the chylomicron fraction was isolated by tube slicing and the volume was recorded by weight. The remaining lymph solution was again complemented with 1.006 g/ml NaCl to a final volume of 1 ml and centrifuged at 120000 rpm for 1 hour and 40 minutes for isolation of the very low density lipoprotein (VLDL) fraction.
Analytical techniques
Plasma lipids were measured using commercially available assay kits from Roche (Mannheim, Germany) for triglycerides and total cholesterol, and from WAKO chemicals GmbH (Neuss, Germany) for phospholipids.
Calculations and statistics
All results are presented as means ± S.D. for the number of animals indicated. Data were statistically analyzed using Student's t-test or ANOVA test with post-hoc Bonferroni correction. Level of significance was set at p<0.05. Analyses were performed using SPSS for Windows software (SPSS, Chicago, IL).
RESULTS
Lymph flow was highly variable between and within individual mice, ranging between 1.0 and 15.8 µl/min per 100 g body weight, but no significant differences in lymph flow were observed between experimental groups and their respective controls (data not shown).
In Mdr2-Pgp-deficient (Mdr2 -/-) mice, biliary phospholipid secretion into the intestine is virtually absent (<0.5 nmol/min per 100 g) (21) . Voshol et al. described that postprandial plasma appearance of chylomicrons is impaired in Mdr2 -/-mice (26) . Figure 1 shows that non-fed Mdr2 To assess the effects of increased biliary phospholipid secretion, we measured lymphatic lipoprotein size and composition in mice after dietary induction of EFA deficiency. Previously, we characterized the effects of EFA deficiency on fat absorption and biliary phospholipid secretion (30) . EFA-deficient (EFAD) mice have a dietary lipid malabsorption ranging between 60-70% of the amount ingested, combined with a 70% increased bile flow and an 83% increased biliary phospholipid excretion. Biliary 
phospholipid acyl chains of EFA-deficient mice contained significantly less essential fatty acids and their long-chain metabolites (i.e., C18:2n-6, C18:3n-6 and C20:4n-6), and more non-essential fatty acids (C16:1n-7, C18:1n-7, C18:1n-9) than EFAsufficient controls (Figure 5a ). Figure 5b shows that at baseline, before enteral lipid administration, lymphatic chylomicrons of EFA-deficient mice were significantly smaller (-32%) than those of EFA-sufficient controls. This decreased particle size in EFA-deficient mice persisted during the active phase of fat absorption, i.e., for two hours after lipid bolus administration (164±28 nm vs. 234±49 nm; p<0.001). Lymph of EFA-deficient mice contained, both absolutely and relatively, more phospholipid and less triglyceride and cholesterol than lymph of EFA-sufficient controls (Figure 6a and 6b). This was associated with a lower core-to-surface ratio in EFA-deficient mice Data represent means ± SD of 6-9 mice per group. *p<0.05, #p<0.005 for differences between EFAD and EFAS mice. lymphatic PL and TG output and an increased lymphatic TG-to-PL ratio in zincdeficient rats, possibly due to limited supply of biliary phospholipids to the enterocytes during zinc deficiency (1) . The lipoproteins secreted by Mdr2 -/-mice were continuously larger during active fat absorption, but strikingly, in non-fasted mice, the size difference was only significant during the first two hours of lymph cannulation.
Since mice had access to chow ad libitum in the night prior to the lymph cannulation experiments, this phenomenon could refer to a delay in intestinal chylomicron formation or transport into lymph (and subsequently into the plasma compartment)
in
Mdr2
-/-mice, as previously postulated (26) . Possibly, the large chylomicrons assembled during intraluminal phospholipid deficiency enter the lymph more slowly than during sufficient intestinal phospholipid availability. This speculation, combined (12) . The application of different methods for quantifying cholesterol absorption, i.e., the plasma dual isotope method and the fecal dual isotope method, respectively, probably explains the discrepancy between these studies. The reduction in plasma high-density lipoprotein (HDL) cholesterol levels noted in both reports is conceivably related to altered chylomicron composition and secretion in Mdr2 -/-mice, since a major part of HDL is thought to be derived from excess chylomicron surface material (phospholipid and cholesterol), shed during the lipolytic process.
The intestinal requirement of phospholipid for production of chylomicrons may be comparable to that of the liver for the assembly and secretion of VLDL. Verkade et al.
demonstrated in choline-deprived rats that during hepatic phosphatidylcholine scarcity, fewer but larger VLDL particles are secreted from the liver (24; 32) . We recently observed that EFA-deficient mice secreted larger VLDL particles from the liver than controls (29) , possibly secondary to hepatic phosphatidylcholine depletion due to increased biliary phospholipid secretion rates.
Animal models for increased biliary phospholipid secretion are relatively rare. Since the profoundly augmented biliary phospholipid secretion rate in EFA-deficient mice affects hepatic lipoprotein size and is associated with dietary fat malabsorption, we considered the EFA-deficient mouse an intriguing model to further study the potentially organ-specific effects of phospholipid availability on intestinal lipoprotein
production. Our data demonstrate that EFA deficiency in mice is associated with lym- (9) . Obviously, in Mdr2-deficiency, an increased TG-to-PL ratio is a highly favorable means to maintain triglyceride packaging into chylomicrons during lack of surface coat material. In addition, up to 20% of lipoprotein phospholipid is thought to be derived from de novo synthesis, and it could be speculated that in biliary phospholipid deficiency, intestinal phospholipids also partially compensates for biliary phospholipids for chylomicron surface coating.
Not only biliary but also enterocytic phospholipids are markedly EFA-depleted during EFA deficiency (10; 11; 16) . The rapid intestinal cellular turnover rate of enterocytes, which is even faster during EFA deficiency (5) , renders the membranes of the intestinal mucosa particularly sensitive to altered intraluminal fatty acid availability. Structural membrane modifications, such as an increased degree of phospholipid fatty acid (31) . Plasma clearance of large chylomicrons is substantially more rapid than that of small particles (18) . Additionally, altered acyl chain composition of EFAdepleted biliary phospholipids on the chylomicron surface affects chylomicron clearance (19) ; chylomicrons with saturated phospholipids are cleared more slowly than chylomicrons with a high content of PUFA in surface phospholipids. Thus, by affecting lipoprotein size and clearance rates, biliary phospholipids may affect plasma and hepatic lipid levels (29) .
Our data are compatible with the concept that the size of intestinal chylomicrons, secreted into lymph under basal conditions or during active lipid absorption, is inversely related to the quantity of biliary phospholipid secretion, and that altered lymphatic lipoprotein size is not necessarily related to net dietary fat absorption as determined by fat balance.
